Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting Condition
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
Primary objective of the present study was to compare the single dose bioavailability of
Torrent's Escitalopram Oxalate Tablet 20 mg [Test formulation, Torrent Pharmaceuticals Ltd.,
India] Versus Lexapro® (Escitalopram Oxalate Tablet 20 mg) [Reference formulation, Forest
Laboratories Inc, USA] . Dosing periods were separated by a washout period during fasted
study.
Study Design:
Open-Label, Randomised, two Period, two treatment, Crossover, Single-Dose Bioequivalence
Study